Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis

Intestinal Research

Volumn 16, Issue 1, 2018, Pages 155-157

  Seo, Hyun Il ^a   Lee, Hyun Ju ^a   Han, Koon Hee ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Colitis; Hyperbaric oxygenation; Pyoderma gangrenosum; Ulcerative

Indexed keywords

EID: 85040687502     PISSN: 15989100     EISSN: 22881956     Source Type: Journal    
DOI: 10.5217/ir.2018.16.1.155     Document Type: Article

References (15)

1. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-585
2. Juillerat P, Christen-Zäch S, Troillet FX, Gallot-Lavallée S, Pannizzon RG, Michetti P. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis: case report and literature review. Dermatology 2007; 215:245-251
3. Brooklyn TN, Dunnill MG, Shetty A, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006;55:505-509
4. Arivarasan K, Bhardwaj V, Sud S, Sachdeva S, Puri AS. Biologics for the treatment of pyoderma gangrenosum in ulcerative colitis. Intest Res 2016;14:365-368
5. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98:1821-1826
6. Argóelles-Arias F, Castro-Laria L, Lobatón T, et al. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci 2013;58:2949-2954
7. Vieira WA, Barbosa LR, Martin LM. Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum. An Bras Dermatol 2011;86:1193-1196
8. Altunay I, Kucukunal A, Sarikaya S, Tukenmez Demirci G. A favourable response to surgical intervention and hyperbaric oxygen therapy in pyoderma gangrenosum. Int Wound J 2014;11:350-353
9. Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Pyoderma gangrenosum: an updated review. J Eur Acad Dermatol Venereol 2009;23:1008-1017
10. Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 2016;10:239-254
11. Braswell SF, Kostopoulos TC, Ortega-Loayza AG. Pathophysiology of pyoderma gangrenosum (PG): an updated review. J Am Acad Dermatol 2015;73:691-698
12. Holmlund DE, Wählby L. Pyoderma gangrenosum after colectomy for inflammatory bowel disease: case report. Acta Chir Scand 1987;153:73-74
13. Cox NH, Peebles-Brown DA, MacKie RM. Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. Br J Hosp Med 1986;36:363
14. Meng X, Zhu X, Chen L, Wu J, Liu G, Xia B. Pyoderma gangreno-sum of articulations carpi associated with ulcerative colitis: one case report. Int J Clin Exp Med 2015;8:19184-19187
15. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996;334:1642-1648